Justice and Due Process

Ban-the-Box: Good or Bad for Ex-Offenders?

It’s imperative to understand that ban-the-box policies are an important step in helping ex-offenders enter into a more equitable and fair labor market.

Libertas Institute Staff
| 15th Dec 2022

Justice and Due Process

Psychotherapeutic Taskforce Top Ten Takeaways

The task force concluded, following months of study, that MDMA and psilocybin (“magic mushrooms”) can offer significant benefits to those with mental illness.

Libertas Institute Staff
| 7th Dec 2022

Justice and Due Process

Douglas Carter and Integrity

Victims deserve finality. A lot of that is out of our control: convicted murderers on death row have every incentive to fight their conviction indefinitely. But by doing the right thing up front, police and prosecutors can ensure convictions are the product of a just process and that they stick, even through all the appeals.

Amy Pomeroy
| 2nd Dec 2022

Justice and Due Process

Ibogaine: A New Option for Addiction?

A humble plant may be able to do what expensive treatment programs can’t: End addiction.

Amy Pomeroy
| 1st Dec 2022

Justice and Due Process

How Safe Are Psychotherapeutics?

Drug policy, like all policy, should be based on facts. In this case, the facts show that psychotherapeutics are safer and less harmful than alcohol and not deserving of their Schedule I classification.

Amy Pomeroy
| 17th Nov 2022

Justice and Due Process

Utah Psychotherapy and Mental Illness Taskforce Finds Psilocybin and MDMA are Safe and Effective

Utah lawmakers are well aware that Utah has the highest rates of mental illness in the nation. In an effort to avail themselves of every available tool, they created the Utah Mental Illness and Psychotherapy Task Force earlier this year. The task force reported its findings, and what they said might surprise you.

Amy Pomeroy
| 14th Nov 2022

Help us Nail and Scale Policies to Reduce Government Control

Your tax-deductible contributions to Libertas Institute increase freedom across the country.